Erlotero 150 Mg Erlotinib Tablets About
Experience the enviable efficacy of ERLOTERO-150, a sought-after anticancer therapy crafted by Zydus Healthcare Ltd. Each box contains 30 film-coated tablets, offering an advanced solution for patients battling non-small cell lung cancer and pancreatic cancer. Easy to redeem with a valid prescription, these tablets are conveniently administered orally. Add to Cart for a superb boost in cancer therapeutics. Strictly regulated under Schedule H, ERLOTERO-150 is a prescription medicine of trusted quality and reliability in oncology care, with a shelf life of 24 months.
Enviable Anti-Cancer Solution with Superb Effectiveness
ERLOTERO-150 Mg Erlotinib Tablets feature film-coated oral tablets designed for targeted cancer therapy, providing significant benefits for patients with non-small cell lung cancer and pancreatic cancer. Manufactured by Zydus Healthcare, this prescription medicine stands out for its reliability and high manufacturing standards, making it a sought-after choice among oncologists. The superb mechanism of action targets specific cancer cell pathways, supporting improved outcomes. Recommended by specialists, ERLOTERO-150 delivers its potent efficacy with confident dependability.
Exceptional Packaging, Certifications, and Easy Supply Offer
ERLOTERO-150 is offered in a robust box of 30 tablets (10 x 3 blister strips), ensuring protection from light and moisture for optimal preservation. With a shelf life of 24 months, every batch meets stringent regulatory standards and comes with official certifications. Take advantage of our quotation system and sample availability for healthcare professionals. Efficient transport services are provided to ensure quick and safe product delivery, making it convenient to redeem and restock this essential medication.
FAQ's of Erlotero 150 Mg Erlotinib Tablets:
Q: How should Erlotero 150 Mg Erlotinib Tablets be administered?
A: Erlotero 150 Mg Erlotinib Tablets are intended for oral administration and should be taken exactly as prescribed by your oncologist or healthcare provider.
Q: What are the primary benefits of using ERLOTERO-150 for cancer treatment?
A: ERLOTERO-150 offers targeted therapy for non-small cell lung cancer and pancreatic cancer, contributing to more effective cancer control with a trusted safety profile.
Q: When is ERLOTERO-150 prescribed and who can use it?
A: This medication is prescribed by oncologists for adults diagnosed with non-small cell lung cancer or pancreatic cancer and is only available with a valid medical prescription.
Q: Where is ERLOTERO-150 manufactured and marketed?
A: ERLOTERO-150 is manufactured by Zydus Healthcare Ltd. and marketed across India, adhering to strict pharmaceutical regulations and standards.
Q: What is the process to redeem ERLOTERO-150 and how can samples be requested?
A: To obtain ERLOTERO-150, present a valid prescription at registered pharmacies or request a quotation for bulk orders. Healthcare professionals may contact authorized suppliers to request samples for institutional evaluation.
Q: How should Erlotero 150 Mg Tablets be stored?
A: Store the tablets below 30C, protected from light and moisture, to maintain their efficacy throughout the 24-month shelf life.